Epistemonikos | Repository

Results: 1 - 10 of 1,024

Total: 1,024 recommendations

HIV and infant feeding. Offer enhanced community- and facility-based interventions to support mothers living with HIV who are breastfeeding in order to optimize ART adherence, improve retention of mother-and-infant pairs in care and optimize breastfeeding

Year: 2025

Institution: 9b2ca34709bbdda8331948ae0fc2898751118c69

Recommended In Favor

Conditional recommendation

Certainty of evidence

Very Low

HIV and infant feeding. In settings where the national programme recommends replacement feeding: mothers living with HIV who are receiving ART and virally suppressed should be offered the choice of breastfeeding and supported in their infant feeding choice.

Year: 2025

Institution: 9b2ca34709bbdda8331948ae0fc2898751118c69

Strongly Recommended In Favor

Strong recommendation

Certainty of evidence

Low

Breastfeeding women who are ≥ 4 weeks postpartum can use an levonorgestrel-intrauterine devices or copper-bearing intrauterine devices without restriction

Year: 2025

Institution: f6c841c60e90d2441ad8987506d40e9766f13da4

Certainty of evidence

Very Low

Breastfeeding women who are ≥ 48 hours to < 4 weeks postpartum should generally not have an levonorgestrel-intrauterine devices or copper-bearing intrauterine devices inserted

Year: 2025

Institution: f6c841c60e90d2441ad8987506d40e9766f13da4

Certainty of evidence

Very Low

Breastfeeding women who are < 48 hours postpartum can generally use levonorgestrel-releasing Intrauterine devices (LNG-IUDs)

Year: 2025

Institution: f6c841c60e90d2441ad8987506d40e9766f13da4

Certainty of evidence

Very Low

Breastfeeding women who are < 48 hours postpartum can use a copper-bearing intrauterine devices (Cu-IUD) without restriction

Year: 2025

Institution: f6c841c60e90d2441ad8987506d40e9766f13da4

Certainty of evidence

Very Low

Breastfeeding women who are ≥ 6 months postpartum can use progestogen-only pills, progestogenonly injectables (depot medroxyprogesterone acetate and norethisterone enantha), and levonorgestrel and etonogestrel implants without restriction

Year: 2025

Institution: f6c841c60e90d2441ad8987506d40e9766f13da4

Certainty of evidence

Low

Women who are ≥ 6 weeks to < 6 months postpartum and breastfeeding can use progestogen-only pills, progestogenonly injectables (depot medroxyprogesterone acetate and norethisterone enantha), and levonorgestrel and etonogestrel implants without restriction

Year: 2025

Institution: f6c841c60e90d2441ad8987506d40e9766f13da4

Year: 2025

Institution: 8b705d7178d487cfaac6e683cca84815831bc2d4

Recommended In Favor

Conditional recommendation

Certainty of evidence

Low

In malaria-endemic areas, pregnant women of all gravidities should be given antimalarial medicine at predetermined intervals to reduce disease burden in pregnancy and adverse pregnancy and birth outcomes.

Year: 2025

Institution: 8ecd10f9bdf31d170a11543d2adeb03e48530fd0

Strongly Recommended In Favor

Strong recommendation

Certainty of evidence

Moderate